Question 1

What is the catalog number for Tissue Total RNA, Prostate?

Accepted Answer

The catalog number for Tissue Total RNA, Prostate is CR560098.

Question 2

What sizes are available for Tissue Total RNA, Prostate?

Accepted Answer

Tissue Total RNA, Prostate is available in the following size(s): 5 µg.

Question 3

Is Tissue Total RNA, Prostate in stock?

Accepted Answer

Tissue Total RNA, Prostate is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

Where can I find the safety data sheet (SDS/MSDS) for Tissue Total RNA, Prostate?

Accepted Answer

The safety data sheet for Tissue Total RNA, Prostate is available here: https://cdn.origene.com/sds/cr560098.pdf.

Question 5

What is Tissue Total RNA, Prostate used for?

Accepted Answer

RNA (5 µg); Prostate; Hyperplasia of prostate

Question 6

What applications has this product been validated for?

Accepted Answer

Validated applications such as WB, ELISA, IHC, ICC, or FC are listed on the product datasheet. If you need application-specific validation data before ordering, contact our technical support team with the catalogue number.

Question 7

How do I reconstitute this lyophilized product?

Accepted Answer

Reconstitution instructions, including the recommended diluent and final concentration, are provided on the datasheet. Aliquot immediately after reconstitution to avoid repeated freeze-thaw cycles.

Question 8

What is the recommended incubation time for this antibody?

Accepted Answer

A suggested incubation time is provided in the recommended protocol on the datasheet, but may need adjusting depending on your sample type and detection system.

Tissue Total RNA, Prostate

Product Specifications

Stability

Storage Conditions

Frequently Asked Questions

Explore Other Products

Mitochondrial Marker (113-1), CF647 conjugate, 0.1mg/mL

Zinviroxime

POLDIP1 (KCTD13) Mouse Monoclonal Antibody [Clone ID: OTI7D5]

Tissue FFPE Sections, Prostate

MMP2 Rabbit Polyclonal Antibody

CCER2 Human Gene Knockout Kit (CRISPR)